Eli Lilly huge outperformer in American pharmaceutical sector

Thanks to the huge profit of 10 percent since begin this year it's one of the best shares of the pharmaceutical sector.

Momentum pharmaceutical sector

On average the sector trades now at 351 times the earnings per share. The sector trades at 41,39 times the book value per share. Since 2012 the sector has a profit of 304 percent and since 2007 a profit of 467 percent.

Over the current book year the company from Indianapolis's total revenue could be around 23,81 billion USD (consensus estimates). This is slightly more than 2019's revenue of 22,32 billion USD.

Historical revenues and results Eli Lilly plus estimates 2020

The analysts expect for 2020 a net profit of 6,62 billion USD. For this year the consensus of Eli Lilly's result per share is a profit of 7,27 USD. The price/earnings-ratio is then 19,82.

For this year the analysts expect a dividend of 2,96 USD per share. Thus the dividend yield equals 2,05 percent. The average dividend yield of the pharmaceutical companies equals a moderate 0,2 percent.

Based on the current number of shares Eli Lilly's market capitalization equals 152,42 billion USD. The Eli Lilly stock was the past 12 months quite volatile. Since last December the stock is even 23 percent higher. This year the stock price moved between 117 and 171 dollar.

Historical stock prices Eli Lilly

Click here for dividend Eli Lilly. At 21.21 the stock trades 2,91 percent higher at 144,11 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.